Summit Therapeutics PLC (NASDAQ:SMMT)

1.24
Delayed Data
As of Jun 14
 -0.02 / -1.59%
Today’s Change
1.10
Today|||52-Week Range
13.39
+7.83%
Year-to-Date

Today’s Trading

Previous close1.26
Today’s open1.29
Day’s range1.23 - 1.30
Volume23,387
Average volume (3 months)53,012
Market cap$61.0M
Data as of 4:00pm ET, 06/14/2019

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-295.05%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+72.54%
P/E ratio1.4
Price/Sales0.40
Price/Book1.09

Competitors

 Today’s
change
Today’s
% change
MTEXMannatech Inc0.000.00%
ATNMActinium Pharmaceuti...+0.00+0.12%
ARPOAerpio Pharmaceutica...-0.01-1.02%
CLSDClearside Biomedical...-0.02-1.89%
Data as of 8:00pm ET, 06/14/2019

Financials

Next reporting dateSeptember 19, 2019
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$57.0M
Annual profit (last year)$10.0M
Net profit margin17.50%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
Glyn Owain Edwards
Chief Operating &
Medical Officer
David Roblin
Corporate headquarters
Abingdon, Oxfordshire

Forecasts